국제약품

002720KOSPI

63.8 / 100

Reference Date: 2026-09-08

Financial Score27.5 / 40

News Sentiment21.3 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 1.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Korea Pharmaceutical Co., Ltd. is a company engaged in the manufacture and sale of specialty and general pharmaceuticals, including Quron Eye Drops and Colensina Soft Capsules. With headquarters in Seongnam and manufacturing/R&D facilities in Ansan, the company achieved a 12.2% increase in consolidated sales to 175,496 million won in fiscal year 2025, while conducting 5 ongoing drug development projects.

Number of Employees

272people

Average Salary

68.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.12Industry Average 15.005.0Point

In line with industry avg

PBR

0.74Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

6.09Industry Average 8.002.5Point

Below industry avg

Debt Ratio

23.09Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲214.6% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 0.5% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
가동률 130% 넘긴 국제약품 안산공장?555억 들여 생산능력 키운다
국제약품의 안산공장 확장 투자로 생산능력이 크게 향상되어 미래 성장 기대감이 높아짐.
Positive
국제약품, 가동률 130% 안산공장 증설…점안제 생산 늘린다
국제약품의 안산공장 증설로 인해 점안제 생산 능력이 향상되어 매출 증대가 기대된다.
Positive
국제약품, 국제피앤비 지분 7% 확대 의도…경영개입 의지
국제약품이 국제피앤비 지분을 확대함으로써 화장품 사업 전문성 강화 의지를 재확인했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (16%, downtrend)

Current 3,395Won52-week high 5,23052-week low 3,045

1-month return3.0Point

1m 1.34% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-09-04
Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-09-04
Neutral신규시설투자등2026-08-24
Neutral반기보고서 (2026.06)2026-08-14
Neutral주식등의대량보유상황보고서(일반)2026-08-11